PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Nature Communications21 citationsOpen Access

Targeted degradation of cell surface proteins through endocytosis triggered by cell-penetrating peptide-small molecule conjugates

View Full Paper
WHWanyi HeCCCongli ChenJZJiwei Zheng

Key Points

  • CPPTACs demonstrate a remarkable ability to degrade clinically significant plasma membrane proteins, including PD-L1 and CAIX.
  • The study reveals that CPPTACs degrade targets without relying on specific lysosome-targeting receptors, broadening their applicability.
  • This method showcases a simpler structural design compared to LYTACs, enabling more accessible drug development strategies.
  • CPPTACs consist of bioactive small molecules combined with cell-penetrating peptides, offering an effective approach for protein degradation.

Abstract

Targeted degradation of membrane-associated proteins, which constitute a crucial class of drug targets implicated in diverse disease pathologies, has garnered considerable attention in chemical biology and drug discovery recently. Taking advantage of the endosomal entrapment of cell-penetrating peptides (CPPs) in delivering bioactive macromolecules, we successfully construct a CPP-based platform for specific degradation of cell surface proteins by conjugation of target protein-binding small molecules (SMs) with different CPPs, resulting in the formation of CPP-mediated lysosome-targeting chimeras (CPPTACs). Through the endo-lysosomal pathway, CPPTACs exhibit a remarkable ability to degrade clinically significant plasma membrane proteins, including PD-L1, CAIX, and CB2R. In contrast to LYTACs and similar technologies, CPPTACs drive the degradation of targets in a manner independent of specific lysosome-shuttling receptors, thus providing a widely applicable strategy for plasma membrane protein degradation, regardless of the cell types. Additionally, simpler structural design and broader therapeutic window for CPPTACs are expected since CPPs-mediated endocytosis and lysosomal degradation do not necessitate the three-component binding model typically required by other heterobifunctional degraders. Overall, consisting of small molecules and biocompatible cell-penetrating peptides, CPPTACs developed in this study represent a simple, adaptable, and effective approach for selectively degrading cell surface proteins in various cellular contexts with potential for application in both biological research and therapeutic interventions. Various cell-penetrating peptides (CPPs) can trigger endocytosis independently of specific lysosome-targeting receptors (LTRs). Here, the authors present CPP-mediated lysosome-targeting chimeras (CPPTACs), a versatile platform that enables the efficient degradation of cell surface proteins without dependence on specific LTRs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

He et al. (2025) studied this question.

synapsesocial.com/papers/68c1c23554b1d3bfb60efadahttps://doi.org/10.1038/s41467-025-62776-w
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemically engineered antibodies for autophagy-based receptor degradation2025 · 28 citations
  2. 2Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation2022 · 172 citations
  3. 3Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore2014 · 95 citations
  4. 4Noninvasive imaging of tumor integrin expression using 18F-labeled RGD dimer peptide with PEG4 linkers2009 · 118 citations
  5. 5Subcellular Trafficking of Mammalian Lysosomal Proteins: An Extended View2016 · 91 citations